CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	7507-7511
Number of pages	4
Journal	Journal of Medicinal Chemistry
Volume	69
Issue number	7
DOIs	https://doi.org/10.1021/acs.jmedchem.6c00866
State	Published - Apr 9 2026

Access to Document

@article{faa4b8035ed44c71bdebe58dc649f03c,

title = "CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease",

author = "Xiaochen Tian and Saghir Ali and John Allen and Jia Zhou",

year = "2026",

month = apr,

day = "9",

doi = "10.1021/acs.jmedchem.6c00866",

language = "English (US)",

volume = "69",

pages = "7507--7511",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "7",

}

TY - JOUR

T1 - CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease

AU - Tian, Xiaochen

AU - Ali, Saghir

AU - Allen, John

AU - Zhou, Jia

PY - 2026/4/9

Y1 - 2026/4/9

U2 - 10.1021/acs.jmedchem.6c00866

DO - 10.1021/acs.jmedchem.6c00866

M3 - Review article

C2 - 41952522

SN - 0022-2623

VL - 69

SP - 7507

EP - 7511

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 7

ER -